News

Search here results

• Orphazyme assumes sponsorship of Phase II/III arimoclomol sIBM trial | Queen Square Centre for Neuromuscular Diseases - UCL – University College London
• Dementia with Lewy bodies: unique genetic profile identified | UCL Queen Square Institute of Neurology - UCL – University College London
• UK DRI awards Faculty researchers £1.5M to study the DNA damage in Huntington's | UCL Queen Square Institute of Neurology - UCL – University College London
• Queen Square Inaugural Lectures | UCL Queen Square Institute of Neurology - UCL – University College London
• Drug lowers deadly Huntington’s disease protein | UCL Queen Square Institute of Neurology - UCL – University College London
• Collaborative work with Dumonceaux and Voit in Nature Communications has important implications for myostatin therapies | Queen Square Centre for Neuromuscular Diseases - UCL – University College London
• Uncertainty and inference | UCL Queen Square Institute of Neurology - UCL – University College London
• Queen Square Inaugural Lectures | UCL Queen Square Institute of Neurology - UCL – University College London
• Improving clinical trials with machine learning | UCL Queen Square Institute of Neurology - UCL – University College London
• IoN celebrates achievements at Annual Address | UCL Queen Square Institute of Neurology - UCL – University College London